disease

Nephropathy

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Nephropathy: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

219Connections

0Hypotheses

0Analyses

50Outgoing

50Incoming

0Experiments

0Debates

No summary available yet.

View on Wiki →

No AI portrait yet

Disease Info

Associated Genes	ANTIOXIDANT GENES, AUTOPHAGY, CCL4, DIABETES MELLITUS, DIABETIC RETINOPATHY, FERROPTOSIS, GENES, GLAUCOMA
Therapeutic Agents	Aconite, Telmisartan
KG Connections	219 knowledge graph edges
Databases	OMIM Orphanet ClinicalTrials PubMed

Pathway Diagram

graph TD
    Nephropathy["Nephropathy"] -->|"therapeutic target"| Oxidative_Stress["Oxidative Stress"]
    Nephropathy["Nephropathy"] -->|"causes"| Diabetes["Diabetes"]
    Nephropathy["Nephropathy"] -->|"associated"| Diabetes_1["Diabetes"]
    Nephropathy["Nephropathy"] -->|"activates"| Ferroptosis["Ferroptosis"]
    Nephropathy["Nephropathy"] -->|"treats"| Als["Als"]
    Nephropathy["Nephropathy"] -->|"treats"| Inflammation["Inflammation"]
    OXIDATIVE_STRESS["OXIDATIVE STRESS"] -->|"therapeutic target"| Nephropathy["Nephropathy"]
    INFLAMMATION["INFLAMMATION"] -->|"treats"| Nephropathy["Nephropathy"]
    INSULIN_RESISTANCE["INSULIN RESISTANCE"] -->|"therapeutic target"| Nephropathy["Nephropathy"]
    CYTOKINES["CYTOKINES"] -->|"therapeutic target"| Nephropathy["Nephropathy"]
    style Nephropathy fill:#ef5350,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0

Outgoing (82)

Target	Relation	Type	Str
Oxidative Stress	therapeutic_target	pathway	0.90
Diabetes	associated_with	disease	0.85
Diabetes	causes	disease	0.85
Ferroptosis	activates	pathway	0.70
Inflammation	treats	disease	0.65
Insulin Resistance	therapeutic_target	disease	0.65
Als	treats	disease	0.65
Als	therapeutic_target	disease	0.65
Type 2 Diabetes	associated_with	disease	0.65
Lipid Metabolism	therapeutic_target	pathway	0.60
Apoptosis	therapeutic_target	pathway	0.60
Ferroptosis	associated_with	pathway	0.60
Cholesterol	therapeutic_target	pathway	0.60
Immune Response	treats	pathway	0.60
Autophagy	associated_with	pathway	0.60
Immune Response	activates	pathway	0.60
Lipid Metabolism	regulates	pathway	0.60
Oxidative Stress	associated_with	pathway	0.60
Tgf-Β	inhibits	pathway	0.60
Nf-Κb	inhibits	pathway	0.60
Mitophagy	activates	pathway	0.60
Inflammasome	activates	pathway	0.60
Oxidative Stress	inhibits	pathway	0.60
Lipid Metabolism	causes	pathway	0.60
Oxidative Stress	causes	pathway	0.60
Mitochondrial Function	causes	pathway	0.60
Phagocytosis	activates	pathway	0.60
Apoptosis	treats	pathway	0.60
Pi3K/Akt	treats	pathway	0.60
Pi3K/Akt	therapeutic_target	pathway	0.60
Mtor	therapeutic_target	pathway	0.60
Insulin Signaling	therapeutic_target	pathway	0.60
Immune Response	therapeutic_target	pathway	0.60
Wnt	therapeutic_target	pathway	0.60
Nf-Κb	therapeutic_target	pathway	0.60
Pi3K/Akt	inhibits	pathway	0.60
Apoptosis	inhibits	pathway	0.60
Autophagy	therapeutic_target	pathway	0.60
Mitophagy	therapeutic_target	pathway	0.60
Wnt	activates	pathway	0.60
Oxidative Stress	activates	pathway	0.60
Nf-Κb	activates	pathway	0.60
Glycolysis	activates	pathway	0.60
Autophagy	inhibits	pathway	0.60
Oxidative Stress	treats	pathway	0.60
Autophagy	treats	pathway	0.60
Stroke	causes	disease	0.55
Hepatitis	inhibits	disease	0.55
Inflammation	inhibits	disease	0.55
Inflammation	interacts_with	disease	0.55

Incoming (137)

Source	Relation	Type	Str
OXIDATIVE STRESS	therapeutic_target	gene	0.95
Doxorubicin	causes	drug	0.90
CYTOKINES	therapeutic_target	gene	0.75
INFLAMMATION	activates	gene	0.75
GENES	associated_with	gene	0.75
DIABETES MELLITUS	causes	gene	0.75
SIRT1	inhibits	gene	0.75
INSULIN RESISTANCE	therapeutic_target	gene	0.75
Telmisartan	treats	drug	0.75
NRF2	activates	gene	0.75
HO-1	activates	gene	0.75
INFLAMMATION	treats	gene	0.75
FERROPTOSIS	activates	gene	0.75
Aconite	treats	compound	0.70
AMPK	therapeutic_target	gene	0.65
RHOA	activates	gene	0.65
ROCK1	activates	gene	0.65
WNT3A	activates	gene	0.65
TNF	therapeutic_target	gene	0.65
NF-ΚB	activates	gene	0.65
Inflammation	activates	disease	0.65
STAT3	inhibits	gene	0.65
NF-ΚB	inhibits	gene	0.65
OXIDATIVE STRESS	causes	gene	0.65
STROKE	causes	gene	0.65
MITOCHONDRIAL DYSFUNCTION	causes	gene	0.65
ROS	causes	gene	0.65
Cardiovascular	causes	disease	0.65
PHAGOCYTOSIS	activates	gene	0.65
GENES	activates	gene	0.65
CD8	activates	gene	0.65
OXIDATIVE STRESS	activates	gene	0.65
PI3K	therapeutic_target	gene	0.65
NF-ΚB	therapeutic_target	gene	0.65
IL-6	therapeutic_target	gene	0.65
INFLAMMATION	interacts_with	gene	0.65
TNF-Α	therapeutic_target	gene	0.65
AKT	therapeutic_target	gene	0.65
JAK	therapeutic_target	gene	0.65
MTOR	therapeutic_target	gene	0.65
Fibrosis	therapeutic_target	disease	0.65
APOPTOSIS	therapeutic_target	gene	0.65
DIABETES MELLITUS	therapeutic_target	gene	0.65
DIABETIC RETINOPATHY	associated_with	gene	0.65
FERROPTOSIS	associated_with	gene	0.65
HBA1	therapeutic_target	gene	0.65
DIABETES MELLITUS	associated_with	gene	0.65
SIRT1	regulates	gene	0.65
SREBP1	regulates	gene	0.65
KEAP1	associated_with	gene	0.65

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning Nephropathy in their description or question text

No additional research found